Clinical Trial Update: Safety and Efficacy of Natalizumab in Combination With Remicade in the Treatment of Crohn's Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial assessed the safety and efficacy of combining natalizumab with infliximab (Remicade) for Crohn's disease; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Remicade (infliximab)
• Tysabri (Natalizumab)

Snippet

Sponsor: Biogen | Conditions: Crohn's Disease | Phase 2 | Status: COMPLETED